ADPT R&D Expenses

Adaptive Biotechnologies Corp · R&D Expenses

ADPT logo

ADPT R&D Expenses

Latest reported$88.21M
ADPT TTM R&D Expenses ($39.16M → $88.21M)
High-resolution chart · PNG

ADPT r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Adaptive Biotechnologies Corp R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
88,208,000
93,189,000
93,769,000
95,198,000
95,692,000
96,911,000
102,953,000
108,507,000
112,877,000
119,761,000
122,117,000
124,593,000
131,718,000
136,518,000
141,756,000
145,233,000
145,647,000
146,410,000
142,343,000
143,475,000
137,717,000
125,909,000
116,072,000
101,430,000
91,622,000
82,157,000
70,705,000
60,583,000
49,860,000
42,785,000
39,157,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.